Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

dc.contributor.authorAhmadzadehfar, Hojjat
dc.contributor.authorRahbar, Kambiz
dc.contributor.authorBaum, Richard P.
dc.contributor.authorSeifert, Robert
dc.contributor.authorKessel, Katharina
dc.contributor.authorBogemann, Martin
dc.contributor.authorKulkarni, Harshad R.
dc.contributor.authorZhang, Jingjing
dc.contributor.authorGerke, Carolin
dc.contributor.authorFimmers, Rolf
dc.contributor.authorKratochwil, Clemens
dc.contributor.authorRathke, Hendrik
dc.contributor.authorIlhan, Harun
dc.contributor.authorMaffey-Steffan, Johanna
dc.contributor.authorSathekge, Mike Machaba
dc.contributor.authorKabasakal, Levent
dc.contributor.authorOsvaldo Garcia-Perez, Francisco
dc.contributor.authorKairemo, Kalevi
dc.contributor.authorMaharaj, Masha
dc.contributor.authorPaez, Diana
dc.contributor.authorVirgolini, Irene
dc.date.accessioned2021-02-15T07:56:50Z
dc.date.available2021-02-15T07:56:50Z
dc.date.issued2021-01
dc.descriptionThis article is part of the Topical Collection on Oncology - Genitourinaryen_ZA
dc.description.abstractPlease read abstract in the article.en_ZA
dc.description.departmentNuclear Medicineen_ZA
dc.description.librarianam2021en_ZA
dc.description.sponsorshipOpen Access funding provided by Projekt DEAL.en_ZA
dc.description.urihttp://link.springer.com/journal/259en_ZA
dc.identifier.citationAhmadzadehfar, H., Rahbar, K., Baum, R.P. et al. Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial) European Journal of Nuclear Medicine and Molecular Imaging, 48, 113–122 (2021). https://doi.org/10.1007/s00259-020-04797-9.en_ZA
dc.identifier.issn1619-7070 (print)
dc.identifier.issn1619-7089 (online)
dc.identifier.other10.1007/s00259-020-04797-9
dc.identifier.urihttp://hdl.handle.net/2263/78552
dc.language.isoenen_ZA
dc.publisherSpringeren_ZA
dc.rights© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License.en_ZA
dc.subjectRadioligand therapyen_ZA
dc.subjectLu-PSMAen_ZA
dc.subjectChemotherapyen_ZA
dc.subjectCastration-resistant prostate cancer (CRPC)en_ZA
dc.subjectMetastatic CRPC (mCRPC)en_ZA
dc.titlePrior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu] Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)en_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ahmadzadehfar_Prior_2020.pdf
Size:
908.06 KB
Format:
Adobe Portable Document Format
Description:
Article
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Nuclear Medicine)
Research Articles (University of Pretoria)
Simple item page